choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Symbyax

Symbyax Newsletter
  • FDA panel backs J&J’s new-class antidepressant 13 Feb 2019 12:01 GMT

    … ;J’s pivotal clinical trials in support of the … antidepressants. If the FDA follows its panel’s advice and approves the drug … approved treatment for treatment-resistant in the US – Lilly’s Symbyax … a contender in phase 3 trials, rapastinel, that could …

  • CCHR Calls FDA Approval of Psychotropics & Electroshock a Colossal Conflict of Interest 06 Mar 2019 14:46 GMT

    antidepressants once touted as “miracle pills,” psychiatrists now claim that the drugs … million for medical device clearance. … Symbyax), quetiapine (Seroquel) and risperidone (Risperdal) have been used with antidepressants … -treatment-to-be-approved-by-fda

  • CCHR Calls FDA Approval of Psychotropics & Electroshock a Colossal Conflict of Interest 07 Mar 2019 00:13 GMT

    antidepressants – once called “miracle pills;” but psychiatrists now claim that the drugs … million for medical device clearance. … Symbyax), quetiapine (Seroquel) and risperidone (Risperdal) have been used with antidepressants … -treatment-to-be-approved-by-fda

  • Drug ‘Special K’ cousin secures FDA approval to treat depression 06 Mar 2019 12:03 GMT

    … and Drug Administration approved Janssen Pharmaceuticals Inc.’s esketamine on Tuesday for treatment … the FDA, there is one other approved medication for treatment-resistant depression, Symbyax, which …

  • FDA approves nasal spray for treatment-resistant depression 06 Mar 2019 09:41 GMT

    … and Drug Administration approved Janssen Pharmaceuticals Inc.'s esketamine on Tuesday for treatment-resistant … . According to the FDA, there is one other approved medication for treatment-resistant depression, Symbyax, which was …

  • FDA approves ketamine-like nasal spray for depression 06 Mar 2019 01:17 GMT

    … and Drug Administration approved Janssen Pharmaceuticals Inc.’s esketamine on Tuesday for treatment … the FDA, there is one other approved medication for treatment-resistant depression, Symbyax, which …

  • J&J’s Spravato breaks depression drought at FDA 06 Mar 2019 11:57 GMT

    … only FDA-approved drug for treatment-resistant depression is Eli Lilly’s Symbyax combination … of licensing the drug, despite mixed results in clinical trials. One study … much more quickly than current antidepressants. That speed of onset has …

  • FDA approves 'club drug' for depression 06 Mar 2019 02:10 GMT

    … ketamine,” Sanacora said. “Most antidepressant drugs are studied up to 8 … Lilly's Symbyax is the only FDA-approved drug for treatment-resistant depression. “ … , diversity in medicine, and new developments in health care research and medical treatments

  • Ketamine-like nasal spray for depression recommended by FDA panel 12 Feb 2019 23:14 GMT

    … Johnson's drug esketamine, a treatment developed to treat … t respond to antidepressants, most of which take … 39;s Symbyax is the only FDA-approved drug for treatment-resistant … trials often show a big placebo response, masking the efficacy of the drug

  • Bipolar medications: Everything you need to know 11 Feb 2019 11:12 GMT

    medication, called Symbyax, is a mix of both an antidepressantFDA has not approved specific antidepressants for the treatment of bipolar, so doctors … Several medications from different drug classes … trial-and-error can help people find the right medication

Satisfied with the content?

Continue to create your account.